Abstract

Kahweol is a diterpene molecule found in coffee that exhibits a wide range of biological activity, including anti-inflammatory and anticancer properties. However, the impact of kahweol on pancreatic β-cells is not known. Herein, by using clonal rat INS-1 (832/13) cells, we performed several functional experiments including; cell viability, apoptosis analysis, insulin secretion and glucose uptake measurements, reactive oxygen species (ROS) production, as well as western blotting analysis to investigate the potential role of kahweol pre-treatment on damage induced by streptozotocin (STZ) treatment. INS-1 cells pre-incubated with different concentrations of kahweol (2.5 and 5 µM) for 24 h, then exposed to STZ (3 mmol/L) for 3 h reversed the STZ-induced effect on cell viability, apoptosis, insulin content, and secretion in addition to glucose uptake and ROS production. Furthermore, Western blot analysis showed that kahweol downregulated STZ-induced nuclear factor kappa B (NF-κB), and the antioxidant proteins, Heme Oxygenase-1 (HMOX-1), and Inhibitor of DNA binding and cell differentiation (Id) proteins (ID1, ID3) while upregulated protein expression of insulin (INS), p-AKT and B-cell lymphoma 2 (BCL-2). In conclusion, our study suggested that kahweol has anti-diabetic properties on pancreatic β-cells by suppressing STZ induced apoptosis, increasing insulin secretion and glucose uptake. Targeting NF-κB, p-AKT, and BCL-2 in addition to antioxidant proteins ID1, ID3, and HMOX-1 are possible implicated mechanisms.

Highlights

  • Diabetes mellitus (DM) is a metabolic condition associated with high blood glucose levels over long periods

  • We tested whether kahweol has a protective effect in INS-1 against STZ-treatment

  • These findings demonstrate that kahweol can protect INS-1 cells against STZ-induced damage

Read more

Summary

Introduction

Diabetes mellitus (DM) is a metabolic condition associated with high blood glucose levels over long periods. The most common types of DM are type 1 and type 2 diabetes. T1D is characterized by β-cell dysfunction and apoptosis due to autoimmune disorder, leading to a lifelong reliance on insulin therapy. T2D is characterized by insufficient insulin and/or insulin resistance [1]. Secreted insulin from pancreatic β-cells maintain normal glucose concentration in circulation [1]. Dysfunctional conditions of pancreatic β-cells, such as apoptosis, glucotoxicity, and oxidative stress, may cause disturbance in insulin production and secretion [2]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call